Rheumatology Medical News about Osteoarthritis, Hip Osteoarthritis, Knee S-Adenosylmethionine

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Lapatinib Helps Subset of Patients with Hepatocellular Carcinoma

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

S-Adenosylmethionine for osteoarthritis of the knee or hip
Cochrane Reviews, 10/22/09

Rutjes AWS et al. – The current systematic review is inconclusive, hampered by the inclusion of mainly small trials of questionable quality. The effects of SAMe on both pain and function may be potentially clinically relevant and, although effects are expected to be small, deserve further clinical evaluation in adequately sized randomised, parallel–group trials in patients with knee or hip osteoarthritis. Meanwhile, routine use of SAMe should not be advised.

<< Previous
Novel expression signatures identified by transcriptional...

Next >>
Update on monthly oral bisphosphonate therapy for the treatment...